Cilastatin, a new therapeutic promise for acute kidney injury
- PMID: 39304269
- DOI: 10.1016/j.kint.2024.07.024
Cilastatin, a new therapeutic promise for acute kidney injury
Abstract
Acute kidney injury is a devasting clinical syndrome resulting from multiple causes, characterized by an abrupt deterioration of kidney function for which there is no pharmacologic treatment. Cilastatin has demonstrated direct nephroprotective effects in acute kidney injury and now is shown to be effective to specifically target therapeutically loaded nanoparticles to the proximal tubule to treat acute kidney injury.
Copyright © 2024 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources